Pharmaceutical companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under its name, each linked to the record.
As of Nov 15, 2026, FDA's public records list Brandywine Pharmaceuticals with 2 drug recalls. The most recent is a drug recall dated Oct 6, 2026: Theophylline Extended-Release Tablets, 100 mg, Rx Only, 100-count bottle, Distributed by….
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
| Oct 6, 2026 | Theophylline Extended-Release Tablets, 100 mg, Rx Only, 100-count bottle, Distributed by: Brandywine Pharmaceuticals, LLC, West Chester, PA Class II · CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory | Drug recalls |
| Oct 6, 2026 | Theophylline Extended-Release Tablets, 200 mg, Rx Only, 100-count bottle, Distributed by: Brandywine Pharmaceuticals, LLC, West Chester, PA Class II · CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory | Drug recalls |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
